Our in vitro and in vivo studies revealed that hyperglycemia significantly increased Keap1 expression and inhibited Nrf2 and NQO1 expression, whereas PET treatment reversed these trends and improved oxidative stress and ferroptosis. The gene discussed is NQO1; the disease is Hyperglycemia.